BG40654A3 - Method for preparing cycloalkyltriazoles - Google Patents
Method for preparing cycloalkyltriazolesInfo
- Publication number
- BG40654A3 BG40654A3 BG7943291A BG4329179A BG40654A3 BG 40654 A3 BG40654 A3 BG 40654A3 BG 7943291 A BG7943291 A BG 7943291A BG 4329179 A BG4329179 A BG 4329179A BG 40654 A3 BG40654 A3 BG 40654A3
- Authority
- BG
- Bulgaria
- Prior art keywords
- cycloalkyltriazoles
- preparing
- preparing cycloalkyltriazoles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT22421/78A IT1094076B (it) | 1978-04-18 | 1978-04-18 | Cicloalchiltriazoli |
Publications (1)
Publication Number | Publication Date |
---|---|
BG40654A3 true BG40654A3 (en) | 1987-01-15 |
Family
ID=11196066
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG7943291A BG40654A3 (en) | 1978-04-18 | 1979-04-18 | Method for preparing cycloalkyltriazoles |
BG98586A BG61367B2 (bg) | 1978-04-18 | 1994-02-25 | Циклоалкилтриазоли |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG98586A BG61367B2 (bg) | 1978-04-18 | 1994-02-25 | Циклоалкилтриазоли |
Country Status (22)
Country | Link |
---|---|
US (2) | US4252721A (xx) |
JP (1) | JPS5817757B2 (xx) |
AT (1) | AT374477B (xx) |
AU (1) | AU520788B2 (xx) |
BG (2) | BG40654A3 (xx) |
CA (1) | CA1104567A (xx) |
CH (1) | CH639847A5 (xx) |
DE (1) | DE2915318A1 (xx) |
DK (1) | DK148480C (xx) |
FI (1) | FI66378C (xx) |
FR (1) | FR2423221A1 (xx) |
GB (1) | GB2020269B (xx) |
HU (1) | HU179917B (xx) |
IE (1) | IE47965B1 (xx) |
IL (1) | IL56926A (xx) |
IT (1) | IT1094076B (xx) |
NL (1) | NL186635C (xx) |
PL (1) | PL116103B1 (xx) |
PT (1) | PT69502A (xx) |
SE (1) | SE437663B (xx) |
SU (1) | SU852174A3 (xx) |
YU (1) | YU41338B (xx) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1248531A (en) * | 1984-04-17 | 1989-01-10 | Jeffrey C. Watkins | 4-substituted piperazine-2-carboxylic acids |
FR2580648B1 (fr) * | 1985-04-17 | 1987-05-15 | Adir | Nouveaux derives du triazole, leur procede de preparation et les compositions pharmaceutiques les renfermant |
US4879294A (en) * | 1988-01-28 | 1989-11-07 | Angelini Pharmaceuticals Ltd. | Opthalmic composition |
IT1224250B (it) * | 1988-06-10 | 1990-09-26 | Acraf | Associzione del depiprazolo con la morfina |
IT1250701B (it) * | 1991-07-24 | 1995-04-21 | Angelini Francesco Ist Ricerca | Composizione farmaceutica solida per uso orale a base di dapiprazolo |
US5288759A (en) * | 1992-08-27 | 1994-02-22 | Alcon Laboratories, Inc. | Use of certain sulfamoyl-substituted phenethylamine derivatives to reverse drug-induced mydriasis |
US6187774B1 (en) | 1996-03-04 | 2001-02-13 | Yoshitomi Pharmaceutical Industries, Ltd. | Fused heterocyclic compounds and pharmaceutical applications thereof |
NZ510685A (en) | 1998-09-30 | 2003-10-31 | Takeda Chemical Industries Ltd | Drugs for improving vesical excretory strength |
IL141235A (en) * | 2000-02-09 | 2012-04-30 | Novartis Int Pharm Ltd | Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the preparation of a drug for the treatment of non-malignant prostatic hyperplasia |
US6730691B1 (en) | 2000-02-10 | 2004-05-04 | Miles A. Galin | Uses of alpha adrenergic blocking agents |
US20020065286A1 (en) * | 2000-08-21 | 2002-05-30 | Davies Michael John | Treatment of wounds |
US20020091129A1 (en) * | 2000-11-20 | 2002-07-11 | Mitradev Boolell | Treatment of premature ejaculation |
CA2454544A1 (en) * | 2001-07-02 | 2003-01-16 | Santen Pharmaceutical Co., Ltd. | Optic nerve protecting agents containing .alpha.1 receptor blocker as active ingredient |
GB0130219D0 (en) * | 2001-12-18 | 2002-02-06 | Pfizer Ltd | Compounds for the treatment of sexual dysfunction |
US20030229001A1 (en) * | 2002-01-31 | 2003-12-11 | Pfizer Inc. | Treatment of male sexual dysfunction |
MXPA05001958A (es) | 2002-08-19 | 2005-04-28 | Pfizer Prod Inc | Terapia de combinacion para enfermedades hiperproliferativas. |
GB0219961D0 (en) | 2002-08-28 | 2002-10-02 | Pfizer Ltd | Oxytocin inhibitors |
US7323462B2 (en) * | 2002-12-10 | 2008-01-29 | Pfizer Inc. | Morpholine dopamine agonists |
CA2451267A1 (en) * | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Pharmaceutical uses for alpha2delta ligands |
PA8597401A1 (es) * | 2003-03-14 | 2005-05-24 | Pfizer | Derivados del acido 3-(1-[3-(1,3-benzotiazol-6-il) propilcarbamoil] cicloalquil) propanoico como inhibidores de nep |
US20040220186A1 (en) * | 2003-04-30 | 2004-11-04 | Pfizer Inc. | PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease |
EA009646B1 (ru) * | 2003-05-30 | 2008-02-28 | Рэнбакси Лабораториз Лтд. | Замещённые производные пиррола и их применение в качестве ингибиторов hmg-coa |
US20050065158A1 (en) * | 2003-07-16 | 2005-03-24 | Pfizer Inc. | Treatment of sexual dysfunction |
US20050037063A1 (en) * | 2003-07-21 | 2005-02-17 | Bolton Anthony E. | Combined therapies |
US7291640B2 (en) * | 2003-09-22 | 2007-11-06 | Pfizer Inc. | Substituted triazole derivatives as oxytocin antagonists |
US20050267096A1 (en) * | 2004-05-26 | 2005-12-01 | Pfizer Inc | New indazole and indolone derivatives and their use pharmaceuticals |
US20050288270A1 (en) * | 2004-05-27 | 2005-12-29 | Pfizer Inc | New aminopyridine derivatives and their use as pharmaceuticals |
EP1863484A1 (en) * | 2005-03-21 | 2007-12-12 | Pfizer Limited | Substituted triazole derivatives as oxytocin antagonists |
WO2006100557A1 (en) * | 2005-03-21 | 2006-09-28 | Pfizer Limited | Substituted triazole derivatives as oxytocin antagonists |
CA2618103A1 (en) * | 2005-08-10 | 2007-02-15 | Pfizer Limited | Substituted triazole derivatives as oxytocin antagonists |
GT200600381A (es) | 2005-08-25 | 2007-03-28 | Compuestos organicos | |
US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
AU2006313430B2 (en) * | 2005-11-08 | 2012-09-06 | Ranbaxy Laboratories Limited | Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt |
US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
US8383660B2 (en) | 2006-03-10 | 2013-02-26 | Pfizer Inc. | Dibenzyl amine compounds and derivatives |
US7919506B2 (en) | 2006-03-10 | 2011-04-05 | Pfizer Inc. | Dibenzyl amine compounds and derivatives |
TW200744583A (en) * | 2006-03-14 | 2007-12-16 | Ranbaxy Lab Ltd | Statin stabilizing dosage formulations |
MX2009000439A (es) * | 2006-07-14 | 2009-02-04 | Ranbaxy Lab Ltd | Formas polimorficas de un inhibidor de hmg-coa reductasa y usos de las mismas. |
CN101663262B (zh) | 2006-12-01 | 2014-03-26 | 百时美施贵宝公司 | 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物 |
CN105143203A (zh) | 2013-04-17 | 2015-12-09 | 辉瑞大药厂 | 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物 |
WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
KR20210096096A (ko) | 2018-10-26 | 2021-08-04 | 오큐파이어 파마, 인크. | 노안, 산동, 및 기타 안구 장애의 치료를 위한 방법 및 조성물 |
CN113574055B (zh) | 2019-01-18 | 2024-07-23 | 阿斯利康(瑞典)有限公司 | Pcsk9抑制剂及其使用方法 |
CN115368310A (zh) | 2021-05-18 | 2022-11-22 | 奥库菲尔医药公司 | 合成甲磺酸酚妥拉明的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2913454A (en) * | 1956-11-23 | 1959-11-17 | Schenley Ind Inc | Certain cycloalkanotriazoles, process and intermediates |
IT1066857B (it) * | 1965-12-15 | 1985-03-12 | Acraf | Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione |
US3472853A (en) * | 1967-05-29 | 1969-10-14 | Sterling Drug Inc | 1-((pyrido(2,1-c)-s-triazolyl)-lower-alkyl)-4-substituted- piperazines |
JPS5070389A (xx) * | 1973-10-30 | 1975-06-11 |
-
1978
- 1978-04-18 IT IT22421/78A patent/IT1094076B/it active Protection Beyond IP Right Term
-
1979
- 1979-03-22 CH CH268579A patent/CH639847A5/it not_active IP Right Cessation
- 1979-03-22 IL IL56926A patent/IL56926A/xx unknown
- 1979-03-29 US US06/025,273 patent/US4252721A/en not_active Expired - Lifetime
- 1979-03-30 NL NLAANVRAGE7902489,A patent/NL186635C/xx not_active IP Right Cessation
- 1979-04-09 AU AU45832/79A patent/AU520788B2/en not_active Ceased
- 1979-04-11 GB GB7912875A patent/GB2020269B/en not_active Expired
- 1979-04-11 YU YU862/79A patent/YU41338B/xx unknown
- 1979-04-11 FR FR7909229A patent/FR2423221A1/fr active Granted
- 1979-04-12 FI FI791217A patent/FI66378C/fi not_active IP Right Cessation
- 1979-04-14 DE DE19792915318 patent/DE2915318A1/de active Granted
- 1979-04-17 HU HU79AI284A patent/HU179917B/hu unknown
- 1979-04-17 CA CA325,782A patent/CA1104567A/en not_active Expired
- 1979-04-17 SE SE7903327A patent/SE437663B/sv not_active IP Right Cessation
- 1979-04-17 SU SU792753553A patent/SU852174A3/ru active
- 1979-04-17 PT PT69502A patent/PT69502A/pt unknown
- 1979-04-17 DK DK156779A patent/DK148480C/da not_active IP Right Cessation
- 1979-04-18 PL PL1979214969A patent/PL116103B1/pl unknown
- 1979-04-18 AT AT0292479A patent/AT374477B/de not_active IP Right Cessation
- 1979-04-18 BG BG7943291A patent/BG40654A3/xx unknown
- 1979-04-18 JP JP54048519A patent/JPS5817757B2/ja not_active Expired
- 1979-08-08 IE IE646/79A patent/IE47965B1/en not_active IP Right Cessation
-
1980
- 1980-08-29 US US06/182,426 patent/US4307095A/en not_active Expired - Lifetime
-
1994
- 1994-02-25 BG BG98586A patent/BG61367B2/bg unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG40654A3 (en) | Method for preparing cycloalkyltriazoles | |
BG38164A3 (en) | Method for preparing n- substanced- 4- piperidanoamides | |
YU170479A (en) | Process for preparing 2-chloro-6-nitroanilines | |
BG40480A3 (en) | Method for preparing phenetanolamines | |
GB2018816B (en) | Process for preparing hexamethyltetrahydronaphthalenes | |
BG31492A3 (en) | Method for obtaining phenetanolamines | |
PT70313A (en) | Process for preparing substituted 1-thia-3-aza-4-ones | |
BG35033A3 (en) | Method for preparing o- metalyloxyphenol | |
DE2962639D1 (en) | Process for preparing 2-chlorosulfinyl-azetidinones | |
GB2019835B (en) | Process for preparing n-carbamoyl-d-thienylglycines | |
DE2960047D1 (en) | Process for preparing 2-oximinophenylacetonitrile | |
DE2961058D1 (en) | Process for preparing alpha-chloro-n-monoalkyl-acetoacetamides | |
YU41093B (en) | Process for preparing 6-deoxy-5hydroxy-tetracycline | |
GB2013180B (en) | Process for preparing n ethylethylenediamine | |
BG40315A3 (en) | Method for preparing auronic derivatives | |
YU40533B (en) | Process for preparing 2-bromoergosinine | |
DE2964629D1 (en) | Process for preparing 3-amino-5-t-butylisoxazole | |
DE2963897D1 (en) | Process for preparing sodium-m-nitrobenzenesulfonate | |
PT67655A (en) | Method for preparing cyano-alquyl-guanidines | |
PH15975A (en) | Process for preparing cis-bicyclooctylamines | |
PT69287A (en) | Process for preparing benzocycloheptapyrans | |
GB2025414B (en) | Process for preparing cis-bicyclooctylamines | |
BG40479A3 (en) | Method for preparing phenylethyr compounds | |
BG29479A1 (en) | Method for 9- bensylharmine obtaining | |
PL112321B2 (en) | Process for preparing alpha-phosphorylthiols |